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Transgenic mice expressing the chemokine N51/KC in thymus, skin, and tongue showed a marked 
infiltration of a single class of inflammatory cells (neutrophils) in the sites of transgene expression. 
In the thymus, neutrophils were most numerous in the cortex andjuxta-medullary regions, often 
forming aggregates or clusters. A similar, but less intense, neutrophilic infiltrate occurred in close 
proximity to the epidermal basal layer of the tongue and skin.  No morphologic evidence of 
injury was observed in the thymus, skin, or tongue of these transgenic  mice, indicating that 
N51/KC expression induces recruitment but not inflammatory activation  of neutrophils.  The 
lack of activation in the thymus resulted in a large senescent neutrophilic population that was 
phagocytosed by thymic macrophages  and epithelial-reticular  cells. These results indicate that 
N51/KC is a neutrophil chemoattractant in vivo and establish these transgenic mice as effective 
models to study the phenomena of recruitment and clearance of neutrophils, events that are critical 
for the initiation and resolution of the inflammatory response. 
M 
ulticellular organisms have developed sophisticated de- 
fense mechanisms to fight physical, chemical, and bio- 
logical aggression. One set of such mechanisms is the inflam- 
matory response. Central to the inflammatory process are the 
phenomena of recruitment, endothelial attachment, and trans- 
migration of neutrophils  and mononuclear phagocytes- 
inflammatory cells that represent the first line of defense  against 
a variety of pathogens (1). Prompt recruitment of neutro- 
phils and monocytes to the site of injury is thought to be 
dependent on the establishment of chemoattractant  gradients 
and on the activation of specific sets of molecules in the en- 
dothelium and in the extracellular matrix (2-5). Molecules 
presumed to determine the establishment  of such gradients 
have been recently characterized and their genes cloned. Struc- 
tural similarities between these molecules have grouped them 
into  a  superfamily  of proteins  known  as  intercrines  or 
chemokines (6, 7). All the peptides in this superfamily are 
cationic, secreted, small (between 70 and 100 amino acids), 
and contain four conserved cysteine residues that form two 
disulfide bonds.  The first disulfide bond is located between 
the first and third cysteine and the second bond between the 
second and fourth cysteine. The position of the two NH2- 
terminal cysteines divides the members into two families. In 
the first family, referred to as chemokine a or "C-X-C" branch, 
the cysteines are separated by one amino acid; in the second, 
referred to as chemokine fl or "C-C" branch, the cysteines 
are adjacent to one another. The best characterized member 
of the first family is IL-8  and of the second is monocyte 
chemoattracting protein 1 (MCP-1). Members of the chemokine 
or C-X-C family also include: (a) platdet factor 4 (PF4); 
(b) human platelet basic protein, which is the precursor of 
the three active peptides:  connective tissue-activating pep- 
tide III, 3-thromboglobulin  (fl-TG), and nentrophil-activating 
peptide  2 (NAP-2);  (c) human GROcffmelanoma growth 
stimulatory activity (MGSA) and its isoforms, GROfl and 
GRO3,; (d) rat cytokine-induced neutrophil chemoattractant 
(CINC); (e) chicken 9E3/CEF4;  ~  human IP-10; and (g) 
mouse monokine induced by IFN-3, (MIG), mouse macro- 
phage inflammatory protein 2 (MIP-2),  and (h) N51/KC. 
N51/KC is an immediate early gene, that encodes a secre- 
tory protein of'o8,000 daltons (8, 9). Induction of N51/KC 
gene expression has been documented in mitogen-stimulated 
fibroblasts (9, 10) and in LPS-stimulated peritoneal and lung 
macrophages (11, 12), endothelial (13) and vascular smooth 
muscle cells (14), but not in a variety of nonstimulated mouse 
tissues (9). The biological role of N51/KC has remained un- 
known to date, but it has been suggested that N51/KC might 
be a neutrophil chemoattractant given its structural homology 
with rat CINC (15). We have recently confirmed this notion 
and demonstrated that N51/KC is able to induce intracel- 
lular Ca  2+ flux and that it binds specifically to neutrophils 
(16).  To  further  understand  the  biological  role  of  this 
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of different promoters in transgenic mice. Results presented 
in this study prove conclusively that N51/KC is a neutrophil- 
specific chemoattractant  in vivo. 
Materials and Methods 
Transgene Construction andMicroinjection.  The N51 cDNA (+2 
to  + 410 bp) was cloned into the BamHI site of the plasmid lck- 
hGH. The lck-hGH plasmid contained the mouse lck promoter 
(-3,200 to  ~-37 bp) and human GH sequences  (+2 to  +2,153 
bp). We substituted sequences located in the Y-untranslated seg- 
ment of N51/KC, which have been postulated to contribute to 
its mRNA's short half-life (10-15 rain) (9), for human growth hor- 
mone (hGH)  1 sequences, which provided introns and poly(A) se- 
quences. For the construction of the K14-N51 transgene,  an EcoKI 
fragment of the lck-N51-hGH transgene was  subcloned into a 
plasmid containing the human K14 promoter (-2.27 kb to ATG). 
Transgenes were restricted from vector sequences by digestion with 
NotI (lck-N51)  and HindlII (K14-N51).  Separation of the trans- 
genes from vector sequences  was accomplished by zonal sucrose 
gradient centrifugation as described (17). Fractions containing the 
transgene were pooled, microcentrifuged through Microcon-100 
filters (Amicon, Inc., Beverly, MA), and washed five times with 
microinjection buffer (5 mM Tris-HCL, pH 7.4, 5 mM NaC1, and 
0.1  mM EDTA). 
Generation of Transgenic Mice. Each transgene was resuspended 
to  a  final  concentration  of 1-5  ng/#l  and  microinjected into 
([C57BL/6J  x  DBA/2]F1; The Jackson Laboratory, Bar Harbor, 
ME) eggs, according to standard methodology. Microinjected eggs 
were transferred into oviducts of ICR (Harlan Sprague Dawley, 
Inc., Indianapolis, IN) foster mothers according to published proce- 
dures (18). By 10 d of life, a piece of tail from the resulting animals 
was clipped for DNA analysis. Identification of transgenic founders 
was carried out by PCR analysis, as previously described (19). Two 
oligonucleotide primers recognizing hGH sequences  (present in 
both lck-N51 and K14-N51 transgenes) were used for the screening 
of transgene incorporation ('5-TTTGGGGTTCTGAATGTGAG- 
3' and 5'-AGGCACTGCCCTCTTGAAGC-Y) and, as an internal 
control, the endogenous/3-thyroid stimulating hormone (TSH) 
gene (5'-GTAACTCACTCATGCAAAGT-3  and 5'-TCCTCAAAG- 
ATGCTCATTAG-Y). These primers amplify 218- and 366-bp seg- 
ments of the hGH and ~-TSH genes,  respectively.  The resulting 
transgenic animals  were kept under pathogen-free conditions. 
RNA Analysis. RNA was extracted from tissues using RNAzol, 
following specifications  from the manufacturer (Cinna/Biotecx, 
Houston, TX). RNA dot blots were performed as described (20). 
An 800-bp fragment of the hGH cDNA was radiolabeled  with 
a random-priming DNA-labeling kit (Amersham Corp., Arlington 
Heights, IL) and was used as a probe in these experiments. The 
RNase protection assays were performed with an KPA II kit (Am- 
bion Inc., Austin, TX) following the manufacturer's instructions. 
For each assay, 20/~g total KNA was hybridized overnight to 5 
x  10  s cpm of the probe, at 42~  The template for the synthesis 
of the RNA probe was a 160-bp fragment of the N51/KC cDNA, 
starting 50 bases 5' of the ATG site, cloned in Bluescript SK II § . 
The template was linearized with XhoI and transcribed with T3 
KNA polymerase to generate the antisense  RNA. The protected 
KNA hybrids were separated in a 6% polyacrylamide gel with 7 
1 Abbreviation used in this paper: hGH, human growth hormone. 
M urea and visualized by autoradiography. For in situ hybridiza- 
tion, a murine cDNA fragment of N51, positions 1-310 (9) was 
cloned into Bluescript KS  +. [3sS]UTP-labeled sense and antisense 
probes were prepared from linearized template DNAs, using T3 
or T7 RNA polymerases (Promega Corp., Madison,  WI). Probes 
were degraded to an average size of 200 nucleotides by limited alka- 
line hydrolysis. After removal of unincorporated nucleotides using 
a Sephadex G-50 column (Pharmacia,  Piscataway, NJ), the labeled 
probes were stored at  -80~  in a solution containing 10 mM di- 
thiothreitol and 1 #g/m1 yeast RNA.  In situ  hybridization was 
performed as previously described  (21). 
Protein Analysis.  Immunopredpitations and Western blots were 
done  essentially  as  described  (22).  Biosynthetic labeling  with 
[3SS]methionine was done as follows:  106 thymic cells from lck- 
N51 transgenic and control mice were isolated and washed twice 
in DMEM lacking methionine, resuspended in 300 #1DMEM con- 
taining I mg/liter methionine and 2.5% dialyzed FCS plus I mCi 
[3SS]methionine/ml,  and incubated overnight (16 h) at 37~  and 
10% CO2. The cells were centrifuged and the immunoprecipitates 
were subjected  to SDS-PAGE,  stained  with Coomassie blue, de- 
stained, treated with Entensify (NEN-DuPont, Boston, MA), and 
exposed to Kodak X-Omat AR film at  -70~  for 7 d. 
Microscopy and Histochemistry.  15 lck-N51 transgenic mice and 
15 age-matched control mice were used in this study.  Animals (n 
=  5/group/time point) were killed  at 15, 50, and 100 d of age. 
Immediately after euthanasia,  the thymus was removed and im- 
mersion fixed in McDowell-Trump solution (23). Tissues for light 
microscopy were processed by routine methods, sectioned at 6 #m, 
and stained  with hematoxylin and eosin (H&E). Quantification 
of neutrophils in the thymus was performed on H&E paraffin-em- 
bedded material. Neutrophils, characterized as a cell with a diameter 
of 10-12 #m with a multilobulated nucleus and granular cytoplasm, 
were counted per high power field (at a magnification of 400). A 
minimum of 20 fields of thymic cortex and 20 fields of medulla 
were evaluated per tissue section. Statistical differences in the mean 
number of neutrophils in the thymus of transgenic mice, as com- 
pared with age-matched controls, were determined by the analysis 
of variance (ANOVA) test with statistical  significance at p g0.05. 
Naphtol AS-D chloracetate esterase histochemical  staining for neu- 
trophils was done essentially  as described by Leder (24). Selected 
tissues for evaluation by transmission  electron microscopy (TEM) 
were post-fixed in 1% osmium tetroxide, dehydrated in a graded 
series of methanol baths, and embedded in epoxy resin. 1 #m-thick 
sections  were cut, stained  with toluidine blue, and examined by 
light microscopy to delineate areas to be evaluated by TEM. Ultra- 
thin sections were placed on copper mesh grids, stained with uranyl 
acetate and lead citrate, and examined with a Zeiss EM-10C trans- 
mission  electron microscope. 
Flow Cytometry.  Flow cytometry was carried out using an Epics 
Profile II flow cytometer and cell sorter (Coulter Corp., Hialeah, 
FL). Thymic cells (106 cells/reaction) were incubated with FITC- 
or PE-labeled antibodies for 30 rain on ice, spun, washed once with 
3% FCS in PBS, and resuspended in 1 ml of the same solution. 
With the exception of F4/80 (Serotec Ltd., Kidlington, Oxford, 
UK) all the antibodies  used for fluorescence-activated  cell sorter 
analysis were purchased from PharMingen (San Diego, CA). An 
average of 20,000 cells was recorded in each case. 
Results 
Generation of Transgenic Animals Expressing the Chemokine 
N51/KC in the Thymus.  Because the expression of this specific 
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Figure  1.  Diagram of the transgenes microinjected  into 
mouse eggs. (,4) The lck-N51 transgene. The murine lck 
promoter drives the expression of the N51/KC cDNA. 
(B) The K14-N51 transgene. The l~uman  keratin promoter 
drives the N51/KC cDNA. In both transgenes, hGH se- 
quences provide introns, exons, and polyadenylation se- 
quences. 
chemokine had not been studied via transgenesis,  the poten- 
tial problem of toxicity and lethality tailored our choice of 
promoter elements. The thymus was selected as the site of 
transgene expression because N51/KC is not expressed in this 
organ (9) and because lesions to the thymus are not incom- 
patible with survival. To target the expression of the trans- 
gene to the thymus, we used the proximal lck promoter fused 
to the cDNA encoding NS1/KC, plus hGH sequences. This 
transgene is referred to here as the lck-N51 transgene (Fig. 
1). Fertilized (C57BL/6J  x  DBA/2J)F1  mouse eggs, were 
injected with the lck-NS1 transgene and transferred to foster 
mothers.  PCR  analysis  of their  offspring resulted in  the 
identification of 11 lck-N51 founder mice. The resuhing trans- 
genic mice were healthy, fertile,  and did not have any ob- 
vious macroscopic phenotype. To obtain a large number of 
animals for expression analysis, we mated nine of the founders 
to wild-type mice and established  eight transgenic lines. 
Transgene  mRNA was detected at varying levels in the 
thymus of all lck-N51 lines tested (Fig. 2). Occasionally, very 
low levels of transgene expression could be detected in the 
spleen, but not in 13 other organs (data not shown); a finding 
that is in agreement with the reported pattern of expression 
of the lck promoter in transgenic mice (25). Transgene mRNA 
was detected at the highest levels in the thymus of lines 48 
and 60. In situ hybridization anal) sis of the thymus of animals 
in these lines revealed prominent transgene expression in the 
cortex and lower levels in the medulla, suggestive of an in- 
creased expression of the transgene in immature T cells (Fig. 
2). Western blot analysis revealed the presence of N51/KC 
immunoreactive  material in the thymus of transgenic animals 
(Fig.  3).  Additional studies involving [3SS]methionine la- 
baling of thymocytes and subsequent immunoprecipitation, 
showed that N51/KC could be readily detected in the media 
of thymocytes  derived from transgenic but not control animals 
(Fig. 3), and that such material was not detected in the cel- 
lular pellets (data not shown), suggesting rapid secretion of 
the N51/KC protein to the extracellular  medium. 
Flow Cytometry Analysis Detects an Increased  Subset of  Gran- 
ulocytes in the Thymus.  Flow cytometry analysis of thymic 
cells from at least three different lck-N51 lines indicated the 
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Figure 2.  lck-N51  transgene 
mtLNA expression in the thymus. 
(~p)  Dot-blot  hybridization  of 
thymus total RNA (10/zg) from 
distinct transgenic lines. (Bottom)  In 
situ  hybridization  analysis  of 
N51/KC in thymus sections of  con- 
trol (A and B) and of a lck-N51 
transgenic mouse of  line 48 (C and 
D). The sections were hybridized 
with N51/KC riboprobes and pho- 
tographed under bright-field (A and 
C) and dark-field (B and/9) illumi- 
nation. (co) Cortex;  (me) medulla. Figure 3.  Expression  of  N51 pro- 
tein  in  the  transgenic mice. (A) 
Thymus cells  isolated  from a lck-N51 
transgenic (Tg) (line 60) and a con- 
trol (C) mouse were lyzed and im- 
munoprecipitated with anti-N51 an- 
tibody. The immunocompl~s, along 
with 100 ng of purified baculovirus 
expressed N51 (N51), were  analyzed 
by SDS-PAGE  and immunoblotting  using anti-N51 antibody. (B) Thymus 
cells isolated  from a control  and a lck-N51 transgenic mouse  (line  48) were 
biosynthetically  labeled overnight with [3sS]methionine. The conditioned 
media were immunoprecipitated with anti-N51 antibody and the im- 
munocomplexes were analyzed by SDS-PAGE and fluorography. 
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Figure  4.  Flow  cytometry analysis of transgenic and control thymic 
cells. (Tbp)  Forward  (IS) and side (SS) scatter analysis. Note the presence 
of a distinct class of cells in the thymus of transgenic animals (lck-N51 
line 48). (Middle)  Thymic  cell suspensions  analyzed for the expression of 
a pan-granulocytic  marker, Gr-1. (Bottom)  Thymic cell suspensions ana- 
lyzed for the expression  of  a neutrophil differentiation antigen recognized 
by the mAb 7/4. (RCN) Relative  cell  number. These  results are represen- 
tative of more than five separate experiments. 
presence of a distinct cell population in the thymus. This popu- 
lation  was composed of cells  not  significantly  larger  than 
thymocytes but of much higher  granularity  (Fig.  4).  Over 
95% of such cells were stained with antibodies directed against 
the granulocytic markers GR-1 and 7/4. The number of posi- 
tive GR-1 cells in the  thymus  of transgenic  mice averaged 
7-10-fold higher than that of control animals (data not shown). 
Since the GR-1 antibody identifies an epitope present on all 
granulocytes,  we sought  to characterize  this population  in 
detail,  using  the  antibody  7/4  that  recognizes  an  antigen 
present solely on neutrophils (26).  In addition, we examined 
whether other cell types could be increased in  the thymus 
of these transgenic  mice.  We did not detect an  increase  in 
the number of F4/80 (monocyte/macrophage lineage)  or NK 
1.1 (NK cells) positive cells, nor could we detect changes in 
the CD4/CD8 T  cell populations (data not shown).  These 
results suggest that the infiltration  is predominantly unicel- 
lular (neutrophils)  and that at least one parameter of T  cell 
differentiation is not significantly affected by the expression 
of the transgene or by the presence of the neutrophils in the 
thymus. 
Characterization of the Cellular Infiltrate in the Tkymus.  The 
thymus was the only organ that contained a prominent cel- 
lular infiltrate during extensive histopathological analysis  of 
the lck-N51 animals.  A rare neutrophil was observed in the 
thymic cortex or medulla of control animals, whereas a marked 
neutrophilic  infiltrate  was present  in  the  thymic cortex of 
all four lck-N51 transgenic lines examined. The neutrophilic 
infiltrate was not accompanied by morphological features of 
injury in the surrounding  tissue as determined by light and 
electron  microscopy,  and  the  severity of the  infiltrate  was 
proportional to the levels of transgene expression. To assess 
whether the presence of neutrophils was associated with an 
increased vascular permeability we used Evan's blue dye. No 
significant differences could be detected among thymuses from 
control and  transgenic mice from lines 48 and 60 (n  =  3, 
data  not  shown),  indicating  that  the  expression  of  the 
chemokine N51/KC did not induce a significant increase  in 
vascular  leakage.  To  further  characterize  the  neutrophilic 
infiltration,  we performed semiquantitative analysis  of neu- 
trophil numbers in thymic sections of animals in line 48. In 
the thymus of these mice, aggregates or dusters of 10 or more 
neutrophils,  often with a perivascular distribution,  were fre- 
quently observed (Fig.  5). Statistically significant (p ~0.05) 
increases in neutrophil counts, as compared with age-matched 
controls, occurred in the thymic cortex oflck-N51 transgenic 
animals at all ages analyzed (Fig. 6). The neutrophilic infiltrate 
of the thymus was greatest in the 15-d-old group. The number 
of neutrophils per unit area decreased over time, and was ap- 
proximately equivalent in the 50- and 100-d-old animals.  De- 
spite the marked infiltration  of the transgenic thymus with 
neutrophils,  we did not detect significant changes in the ab- 
solute or relative numbers of circulating granulocytes, lym- 
phocytes, red cells,  or platelets  (data  not  shown). 
In addition to a significantly increased number of neutro- 
phils,  the thymus of 50- and  100-d-old  transgenic  animals 
contained  cells  with  bright  eosinophilic,  spindloid,  in- 
2042  N51/KC  Expression in Transgenic Mice Figure 5.  Light photomicrographs  of the thymus of 15-d-okl mice. No chloroacetate  esterase  (CAE)-pmitive  cells, indicative  of neutmplffls,  are 
present  in the control  thymus  (.4), whereas  numerous  CAR-positive  ceils  are  present  in the lck-N51  (line  48) tramge,ic  mouse  (/3). (A and  B) Bars: 100/an. 
tracytoplasmic inclusions. Ultrastructural analysis indicated 
that such ~  were thymic  macrophages and epithelial-reticular 
cells (Fig. 7). The number of macrophages in the transgenic 
thymus, however, remained unchanged; we were not able to 
detect an increase in the number of tissue macrophages by 
flow cytometry  or by immuno~tochemistry using the 1=4/80 
antibody (data not shown), indicating that monocytes were 
not being recruited to the thymus as a consequence of trans- 
gene expression. Both cell types often contained numerous 
crystalloid inclusions that greatly distended the cytoplasm, 
and in some instances, perforated the cell membrane. These 
inclusions, which were similar in both cell types, were con- 
tained in lysosomal structures, and were characterized as elec- 
tron dense, rod-shaped, linear crystalloid structures measuring 
up to 7.5 ~tm in length, with straight sides and blunt, tapering 
ends (Fig.  7). Several crystalloid inclusions lying parallel to 
one another were occasionally seen. Other rod- or irregular- 
shaped crystalloid inclusions were enmeshed with granular 
dectron-dense material and lipid, characteristic of lipofuscin 
or residual bodies. 
In addition to intracytoplasmic crystalloid inclusions, mac- 
rophages and epithelial-reticular cells also contained phagocy- 
tized cellular and nuclear debris, with characteristics of de- 
generative  or  necrotic  nentrophils  in  varying  stages  of 
apoptosis. Degenerative nentrophils, characterized by a frag- 
mented, condensed dectron-dense nudens and cytoplasm con- 
raining primary granules, were frequently observed. The de- 
generative nentrophils were contained within,  or partially 
enveloped by, macrophage or epithelial-reticular cell pseu- 
dopodia (Fig.  7). 
ExlYression of  N51/KC in the Epidermis also Results in a Neu- 
trophilic Infiltrate.  Since the expression of N51/KC  in the 
thymus resulted in a neutrophilic infiltrate that did not in- 
duce injury, we decided to probe its chemotatic nature by 
expressing it in other tissues.  The reasons for this were two- 
fold: first, to ask whether the nentrophil chemmttractant prop- 
erties of N51/KC were independent of the tissue substrate; 
and, second, to investigate whether the nature of  the in61trate 
would remain the same.  We selected the epi&,.,is  as our 
next target tissue because it has a reduced granulocytic and 
lymphoid background and because it provides a convenient 
experimental access. To target the expression of N51/KC m 
the skin and other stratified epithelia, we used a 2.3-kb seg- 
ment of  the human keratin 14 promoter fused m the N51/KC 
cDNA plus hGH sequences (t~-6axed to here as the K14-N51 
tramgene). This promoter targets the expression of trans- 
~  to moa amifad ~  epitl~ ~lnding ep~m~ 
tongue, and esophagus (27).  We generated seven founders 
bearing the K14-N51 transgene. To examine K14-N51 trans- 
gene expression, we carried out RNase protection experi- 
ments in founders and their offspring. Skin and tongue RJqA 
from animals in lines 35 and 38, but not that of the other 
founders  or  control  mice,  completely protected  the  321)_ 
labeled riboprobe (rig. 8). Thus, in this set of transgenic ex- 
periments, the penetrance was reduced (two expressing lines 
out of seven) when compared with that obtained with the 
lck-N51 transgene (eight expressing lines out of eight) and 
the levels of expression were severalfold lower when com- 
pared with that of lck-N51 animals. Notwithstanding the 
low levels of transgeue expression, a higher number of nen- 
trophils was observed in the tongue and tail skin of the ex- 
pre&~ing  ~  (35 and 38) than in age-matched  controk Similar 
to what was observed with the it.k-N51 wamgem, the infiltrate 
in tongue and skin was nentrophilic and not associated with 
any morphologic features of  injury. The neutrophilic infiltrate 
in  the tongue was adjacent to  and within  the squamous 
mucosa, whereas the neutrophilic infaltrate in the skin was 
observed in close proximity to the outer root sheath cells of 
the hair follicles  and the basal layer of the epidermis (Fig. 
9). The presence of  nentrophils in these areas most likely results 
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Figure 6.  Quantification of neutrophils in the thymus of control and 
lck-N51 transgenic mice. Columns represent mean number of polymor- 
phonuclear neutrophils (PMN)  per high powered field (PMN/HPF). (*) 
Statistically increased over age-matched controls (ANOVA, p g0.05). Error 
bars  =  _+  SEM (n  =  five animals). 
from local transgene expression,  since these cells represent 
known sites for K14 gene expression (27, 28). The chronic 
expression of N51 in these compartments to date (>50 d of 
age) has not affected the growth of the skin and adnexa, nor 
resulted in healing abnormalities or tumors. 
Discussion 
Results from this study indicate that transgenic mice chron- 
ically expressing the N51/KC chemokine have a significant 
neutrophilic infiltrate in the sites of transgene expression. In 
these tissues, the neutrophils are distributed in close prox- 
imity to cells expressing the transgene and often around vessels. 
The perivascular  distribution and subsequent distribution 
throughout the parenchyma of these tissues, imply that the 
neutrophils migrate from the vascular lumen into the adja- 
cent parenchyma. These results conclusively demonstrate that 
the N51/KC chemokine functions as a neutrophil chemoat- 
tractant in vivo.  Whereas it is possible  that some of the 
chemotactic role of N51/KC may be mediated indirectly, via 
generalized activation of the endothelium, the striking pat- 
tern of neutrophil infiltration in the vicinity of cells expressing 
the N51/KC chemokine in both transgenic models argues 
in favor of a direct chemoattractant role for this molecule. 
Reinforcing this notion is the recent experimental evidence 
that N51/KC binds and induces intracellular calcium changes 
in human neutrophils (16). 
The presence of neutrophils in the parenchyma indicates 
that the N51/KC chemokine  is capable of activating a number 
of processes that allow for neutrophilic infiltration, including 
transendothelial and basement membrane migration and navi- 
gation throughout the intercellular space. These phenomena 
are thought to be active in nature, and have not been con- 
veniently modeled because of lack of a suitable animal system. 
We began to analyze the process of neutrophil infiltration 
in the thymus by quantitating the number of neutrophils at 
different ages. In the thymus, the greatest degree of neutro- 
phil infiltration was present in the younger animals (<15 d 
of age). Although still significantly greater than age-matched 
controls, the number of neutrophils in the thymus decreased 
at later time points, i.e., at 50 and 100 d of age. This reduc- 
tion in neutrophil numbers, however, cannot be ascribed to 
reduced transgene expression because there is no significant 
decrease in mRNA expression at those time points (data not 
shown). The specific mechanism responsible for this reduc- 
tion remains to be elucidated but may reside in a reduction 
in active recruitment followed by senescence and death of 
the resident neutrophil population. The average half-life of 
neutrophils in the blood is 6 h after their release from the 
bone marrow (29).  After neutrophils migrate into tissues, 
they do not return to circulation, but remain in the tissue 
spaces for '~ 1-2 d and undergo apoptosis if left unstimulated 
(29, 30). The precise mechanisms involved in disposal of senes- 
cent neutrophils are not well understood, but it has been 
known since Metchnikoff  (31) that they can be phagocytosed 
by macrophages. In the present study, the decrease in thymic 
neutrophils in older mice was associated with the presence 
of bright, eosinophilic cells with cytoplasmic inclusions that 
we identified as macrophages and epithelial-reticular cells. Such 
phenomenon was observed in the thymuses of transgenic mice 
from three distinct pedigrees, which rules out the possibility 
that it might have been due to a position effect. Although 
one cannot exclude the possibility that the appearance of cy- 
toplasmic inclusions was a consequence of a direct action of 
N51/KC on those cells, the presence of cytoplasmic inclu- 
sions on macrophages engaged in active phagocytosis of de- 
generating neutrophils strongly suggests that such inclusions 
may represent a phagocytic byproduct. CrystaUoid inclusions 
2044  N51/KC Expression  in Transgenic Mice Figure 7.  Transmission electron micrograph  of a thymus of a 200-d-old lck-N51 transgenic mouse. Several neutrophils  (N) are in close proximity 
to thymic macrophages (M) that contain numerous crystalloid inclusions. Macrophage pseudopodia (arrows)  surround an apoptotic neutrophil.  Section 
stained with lead citrate and uranyl acetate. Bar, 5 #m. 
in macrophages, with characteristics similar to those described 
in the present  study, have also been reported in the perito- 
neal macrophages of adult mice administered bully-coat white 
cells (32), in the bone marrow of mice with myeloid leukemia, 
and in bone marrow, spleen, lung, iUeum, and Kuppfer cells 
of liver but not thymus of aged mice (33). It has been postu- 
lated that such inclusions represent  phagocytic byproducts 
of granulocytes  (33). By electron microscopy, degenerating 
granulocytes have also been identified in the cytoplasm of the 
peritoneal macrophages (32), glomerular macrophages (34), 
Figure 8.  K14-N51 transgene expression in tongue and skin of trans- 
genic and control mice. Total RNA (10 #g) was used for these RNase 
protection experiments. As positive control (kk-N51  Ttry), we used 2 #g 
of thymus RNA from a lck-N51 animal (line 48). (t~ Founder; (p) progeny. 
and macrophages  from acutely inflamed joints (35). Thus, 
the recognition of senescent but otherwise intact neutrophils 
by  phagocytic  cells, including  thymic  macrophages  and 
epithelial-reticular cells, may represent an injury-limiting neu- 
trophil disposal mechanism, important in the normal resolu- 
tion of inflammation. 
Previous studies using transgenic mice have reported that 
expression of cytokines can result in an overt inflammatory 
response or in severe hematopoietic abnormalities.  In some 
cases, the granulocytic infiltration  seems to be the product 
of a strong proliferative stimulus for a given cell lineage, as 
observed in transgenic  mice overexpressing the IL-5 gene, 
which develop splenomegaly and the full pathway of eosino- 
phil differentiation with massive eosinophilia (36, 37). In other 
cases, the inflammatory component  seems to  result  from 
recruitment of several different cells to the site and activation 
of synthesis and release of a variety of inflammatory medi- 
ators. Allison et al. (38) have  demonstrated that mice expressing 
the IL-2 gene in the pancreas develop pancreatitis  affecting 
predominantly the exocrine pancreas with progression to di- 
abetes and subsequent death. The inflammatory reaction was 
characterized by massive numbers of macrophages, some lym- 
phocytes~ and eosinophils. In animals surviving to weaning 
age, the pancreatitis resolved into a peri-islet infiltrate com- 
prising mainly small lymphocytes  and some macrophages. 
Similarly, Katsuki et al. (39) demonstrated a perivascular lym- 
2045  Lira et al. Filcare 9.  Light photomicrographs of the tongue of a 52-d-old control (A) and K14-N51  transgenic (B) mouse.  A rare CAE-positive cell is present 
in control tongue, whereas numerous CAE-positive cells with morphologic characteristics  of neutrophils, are observed in the squamous  epithelium 
and l~in~ propria of the tongue of the transgeaic animal. Light photomicrograph of the skin from the tail of 22-d-old control (C) and K14-N51 
tramgenic (D) mouse.  The epidermis and superficial dermis of transgenic animals contain several neutrophils (arrows) (H & E). Bars:  (A-D) 50 #m. 
phocyte accumulation in the cerebellar meninges which was 
followed by increased cell infiltration of neutrophils and mono- 
cytes in the cerebdhm in uamgenic  mice  with an intact human 
genomic  IL-2  gene  or  a  mouse  metallothionein I  pro- 
motet-human IL-2 chimeric geue. A  multicellular inflam- 
matory reaction is also observed in mice expressing TNF genes 
in their  joints (40), skin (41), or pancreas (42-44) and in mice 
expressing IL-10 in the pancreas (45). Yet, in other studies, 
the expression of cytokines results in an inflammatory pro- 
cess in areas not associated with the transgene expression. 
Transgenic mice overexpressing IL-4 in the thymus, develop 
an inflammatory occular lesion (blepharitis)  with character- 
istic  histopathological  features  seen  in  allergic  reactions 
(mononudear cells and a striking number of eosinophils). 
In the thymus, IL-4 transgene expression perturbs T cell matu- 
ration, reducing the number of double positives and periph- 
eral T cells, but does not result in recruitment of inflamma- 
tory cells (46,  47).  In contrast to these well characterized 
transgenic models, the cellular infiltrate resulting from the 
overexpression of N51/KC is monoceUular, restricted to the 
site of transgene expression,  and is benign in nature. The 
lack of a full-blown inflammatory reaction to the chronic ex- 
pression of N51/KC suggests that under physiological con- 
ditions, N51/KC functions primarily as a chemoattractant 
molecule, and that the inflammatory activation of neutro- 
phils (i.e., degranulation) requires other inflammatory medi- 
ators. The rapid activation of N51/KC in fibroblasts, macro- 
phages, and the endothelium might therefore, constitute one 
of the first levels of response towards lesion, ensuring the 
arrival of a particular class of cells to the site of injury. 
The most relevant feature of the N51/KC transgenic models 
described here is the genetically programmed recruitment of 
a single class ofinfhmmatory  cells to a particular tissue. These 
models, therefore, will be particularly useful to study the phys- 
iological pathways required for the establishment of the inflam- 
matory response. Given the striking specificity of N51/KC 
towards neutrophils, these models will be useful to study the 
mechanisms involved in diapedesis, providing much needed 
information on the interactions of neutrophils with the en- 
dothelial wall, and serve as valuable animal models in which 
to evaluate compounds that affect such interactions. Other 
long-standing questions on inflammation, such as the nature 
of the chemotactic gradient, may also be addressed by these 
models. The distinction between fluid- or solid-phase chemo- 
tactic gradients has not been possible up to now, because the 
chemotactic assays currently available rely on the establish- 
2046  N51/KC  Expression  in Transgenic  Mice ment of fluid-phase gradients. Since C-C and C-X-C chemokine 
family members bind negatively charged proteoglycans (4) 
it is possible that they could bind to chemically related sub- 
stances (glycosaminoglycans) in the vessels or in the tissue 
parenchyma to form a solid- rather  than a fluid-phase gra- 
dient. Evidence in favor of the formation of solid-phase gra- 
dients has been recently obtained for chemokines such as IL- 
8 (48) and MIP-lfl  (49).  Therefore,  these transgenic  mice 
might offer the opportunity to further discriminate between 
these gradient models. Finally, the N51/KC transgenic models 
may also contribute to our understanding of the fate of the 
infiltrating neutrophils, an issue that is central to the resolu- 
tion of the inflammatory response. 
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